Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.4 (trypsin)
 42,187 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Immunohistologic investigations of wound healing in human oral mucosa require specific cell biological markers as well as consecutive small biopsies. Small specimens are ideally embedded in plastic (methylmethacrylate, MMA) resin due to their miniature size. This limits the use of antibodies for these markers. In this immunohistochemical study, the distribution of wound healing markers, e.g. cytokeratin (CK), laminin, collagen IV, vimentin, vinculin and fibronectin, were compared between semithin sections of plastic-embedded tissue and frozen sections of mucosal tissue in order to assess their use for future investigations. The antibodies against laminin, collagen IV and CK 1/2/10/11, 5/6, 13, 14, 17, 19 gave comparable staining patterns on cryostat sections of attached mucosa and on semithin sections of MMA-embedded attached mucosa. In the epithelial cell layers, the following distribution of CK immunostaining was observed: The basal cell layer was positive for CK 5/6, CK 14 and CK 19; the intermediate cell layer for CK 13, CK 17 and CK 1/2/10/11, and the superficial cell layer for CK 13 and CK 1/2/10/11. For most of these antibodies, enzyme digestion with 0.1% trypsin was adequate for demasking the antigens, except for anti-CK 14, anti-CK 17 and anti-laminin; predigestion with 0.4% pepsin in 0.01 N HCl gave similar staining results. The antibodies against vimentin, vinculin, fibronectin and CK 4 showed no affinity or a reciprocal reaction on the semithin sections. Therefore, the antibodies against CK 1/2/10/11; 5/6; 13; 14; 17, and 19, as well as the basement proteins laminin and collagen IV are deemed markers suitable on semithin sections of plastic-embedded attached oral mucosa.
 ...
PMID:Immunohistochemical comparison of markers for wound healing on plastic-embedded and frozen mucosal tissue. 1895 37

Quantitative proteomics requires novel analytical methodology to fill the gap related to absolute protein abundance in different physiological conditions. In this paper, we demonstrate a proof-of-concept study for absolute protein quantification. 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic acid-10-maleimidoethylacetamide (MMA-DOTA) loaded with Eu was used to label lysozyme, insulin, and ribonuclease A, and they were subsequently quantified using HPLC coupled with (153)Eu species-unspecific isotope dilution inductively coupled plasma mass spectrometry (ICPMS). Labeling procedures were optimized using electrospray ionization mass spectrometry (ESI-MS) based on the labeling efficiency and specificity of the three intact proteins, which suggested that 10-fold or higher MMA-DOTA to cysteine sulphydryl rates at pH from 6.8 to 7.6 and 47 degrees C for 40 min were optimal conditions for the conjugation of the reduced-form proteins and that a 5-fold excess of Eu with respect to the DOTA present in the MMA-DOTA-conjugated proteins and pH 5.8 are optimal for Eu labeling. Subsequently, these three MMA-DOTA-Eu-labeled proteins were digested with trypsin, and the tryptic peptides were quantified via HPLC coupled with (153)Eu species-unspecific isotope dilution ICPMS. The results for the protein studied indicated that not only could 100% digestion efficiency not be achieved but also the resulting peptides needed a chromatographic separation at higher resolution. On the other hand, the labeled intact proteins were quantified without tryptic digestion. The average recovery was found to be 97.9% in six independent experiments, and the precision was evaluated to be 5.8% at the 10 pmol L(-1) level. The detection limits (3sigma) were determined to be 0.819, 1.638, and 0.819 fmol for lysozyme, the A chain of insulin, and ribonuclease A, respectively, using ICPMS with a normal concentric pneumatic nebulizer. These results demonstrated that high-quality absolute protein quantification could be achieved through labeling the intact proteins but not the tryptic peptides, implying that intact proteins may be more feasible and practical targets than tryptic peptides for ICPMS-based absolute protein quantification.
 ...
PMID:Absolute quantification of intact proteins via 1,4,7,10-tetraazacyclododecane-1,4,7-trisacetic acid-10-maleimidoethylacetamide-europium labeling and HPLC coupled with species-unspecific isotope dilution ICPMS. 2009 9

Protein-polyelectrolyte complexes are very interesting systems since they can be applied in many long-established and emerging areas of biotechnology. From nanotechnology to industrial processing, these complexes are used for many purposes: to build multilayer particles for biosensors; to entrap and deliver proteins for pharmaceutical applications; to isolate and immobilize proteins. The enteric copolymer poly(methacrylic acid-co-methyl methacrylate) 1:2 (MMA) has been designed for drug delivery although its chemical properties allow to use it for other applications. Understanding the interaction between trypsin and this polymer is very important in order to optimize the mechanism of formation of this complex for different biotechnological applications.The formation of the trypsin-MMA complex was studied by spectroscopy and isothermal titration calorimetry. Structural analysis of trypsin was carried out by catalytic activity assays, circular dichroism and differential scanning calorimetry. Isothermal titration calorimetry experiments showed that the insoluble complex contains 12 trypsin molecules per MMA molecule at pH 5 and they interact with high affinity to form insoluble complexes. Both electrostatic and hydrophobic forces are involved in the formation of the complex. The structure of trypsin is not affected by the presence of MMA, although it interacts with some domains of trypsin affecting its thermal denaturation as seen in the differential scanning calorimetry experiments. Its catalytic activity is not altered. Dynamic light scattering demonstrated the presence of a soluble trypsin-copolymer complex at pH 5 and 8. Turbidimetric assays show that the insoluble complex can be dissolved by low ionic strength and/or pH in order to obtain free native trypsin.
...
PMID:Characterization of the Interaction Between Pancreatic Trypsin and an Enteric Copolymer as a Tool for Several Biotechnological Applications. 2661 27